Misdiagnosis of different types of aneuploidy in preimplantation genetic testing (PGT): a systematic review and meta-analysis
Clinical Snapshot
PICO Framework
| P — Population | Embryos undergoing preimplantation genetic testing for aneuploidy (PGT-A) in assisted reproductive technology cycles |
| I — Intervention | Trophectoderm (TE) biopsy for genetic testing |
| C — Comparator | Inner cell mass (ICM) or whole blastocyst (WB) genetic analysis as reference standard |
| O — Outcomes | Diagnostic accuracy, misdiagnosis rates, discordance rates between TE and ICM/WB results for different aneuploidy types |
Bottom Line
This meta-analysis of 22 studies reveals significant diagnostic limitations in current PGT-A practices, particularly for segmental aneuploidies which show a 17.4% discordance rate between trophectoderm biopsy and actual embryo genetics. The 10-fold increased odds of misdiagnosis for segmental aneuploidies (OR 10.04) suggests that current practice may inappropriately discard viable embryos. While overall euploid diagnosis remains highly accurate (97.4%), the substantial misclassification of aneuploid embryos - especially segmental types - warrants immediate attention. Clinicians should exercise increased caution when counselling patients about embryos with segmental aneuploidy diagnoses, potentially considering confirmatory testing or modified transfer protocols. This evidence challenges the binary approach to PGT-A results and supports emerging concepts of embryo mosaicism and self-correction. Australian fertility specialists should review current protocols for interpreting segmental aneuploidy results and consider developing more nuanced counselling approaches that acknowledge diagnostic uncertainty while maintaining appropriate clinical standards.
Key Findings
P Value: P < 0.001
Effect Size: OR = 10.04 for segmental aneuploidy misdiagnosis in PGT-A population
Primary Outcome: Discordance rates between trophectoderm biopsy and inner cell mass/whole blastocyst genetic analysis
Nnt Or Sensitivity: Segmental aneuploidy discordance rate: 17.4% vs 2.6% for euploid embryos
Confidence Interval: 95% CI: 7.60-13.27
Clinical Application
Highly feasible - requires modification of existing PGT-A interpretation protocols rather than new technology Directly relevant to Australian fertility clinics offering PGT-A. May influence NHMRC guidelines and RTAC standards for genetic testing interpretation. Cost implications for Medicare-funded IVF cycles if additional confirmatory testing recommended. Couples undergoing IVF with PGT-A, particularly those with embryos diagnosed with segmental aneuploidies
Abstract
PURPOSE: Recent studies have reported that embryos diagnosed as aneuploid by preimplantation genetic testing (PGT) can still result in successful live births after transfer. This suggests that, in addition to mosaic embryos, fully aneuploid embryos may also carry a risk of diagnostic error, potentially reducing the overall accuracy of PGT. Therefore, thoroughly investigating the risk and characteristics of aneuploidy misdiagnosis is crucial for optimizing PGT strategies and improving clinical outcomes in assisted reproductive technology (ART). METHODS: Relevant studies published from January 2000 to December 2024 were identified through PubMed and Web of Science. Study quality was assessed using the Newcastle-Ottawa Scale (NOS). A diagnostic meta-analysis was conducted using a random-effects model to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs), combining sensitivity and specificity. Results were visualized using forest plots. RESULTS: A total of 22 studies were included to assess the discordance between trophectoderm (TE) biopsy and inner cell mass (ICM) or whole blastocyst (WB) results. The discordance rate for euploid embryo diagnosis was low (2.6%), whereas it was significantly higher for aneuploid embryos (9.2%). Segmental aneuploidies showed the highest discordance rate (17.4%). In the PGT-A population, misdiagnosis of segmental aneuploid embryos was particularly prominent (OR = 10.04, 95% CI: 7.60-13.27, I2 = 0%, P < 0.001). CONCLUSION: The results indicate that embryos with segmental aneuploidies have a significantly higher risk of misdiagnosis, especially in the PGT-A population. This highlights the need for caution when interpreting trophectoderm (TE) biopsy results involving segmental aneuploidies, to avoid misdiagnosis and the inadvertent discard of potentially viable embryos.
References
- 1.Jiang, W., Hu, Z., Han, Y., Shi, J., Chen, K., Lian, Y., Li, W., Hao, P., Zhou, Z., Wu, Z., Li, Y., Wu, X., Li, M., Deng, L., Zheng, H., Bi, Z., Ding, L., Pan, X., Ma, R., Tang, Z., Mu, J., Xie, X., Li, Y., & Yan, J. (2026). Misdiagnosis of different types of aneuploidy in preimplantation genetic testing (PGT): a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. https://doi.org/10.1016/j.fertnstert.2022.10.010
Related Research
Biology of reproduction
Noninvasive pre-transfer identification of women with recurrent implantation failure using a plasma microRNA-based machine learning model
16 July 2026
ACS biomaterials science & engineering
A Review of Biomass-Derived Nanomaterials as Functional Interfaces for Advanced Electrochemical Hormone Detection
14 July 2026
European journal of clinical pharmacology
Clomiphene citrate versus testosterone replacement therapy in male hypogonadism: a systematic review of literature and meta-analysis
13 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service